The High Court of Bangladesh has released a full verdict stating that the government, not pharmaceutical companies, will determine the prices of life-saving medicines. The ruling, published on November 24, follows a public interest litigation filed by Human Rights and Peace for Bangladesh against a 2018 circular that limited the government’s authority to price only 117 essential drugs. The court, led by Justices Rezaul Hasan and Biswajit Debnath, declared the circular illegal and directed relevant authorities to fix and publish the prices of life-saving drugs in the official gazette. The petitioners argued that restricting government control over drug pricing infringes upon citizens’ right to life and health. The decision reinstates the government’s full authority under the 1982 Drug Control Ordinance, reversing earlier limitations imposed in 1994 that allowed manufacturers to set prices for most medicines.